SEKORIE

Serial Number 86974576
606

Registration Progress

Application Filed
Apr 13, 2016
Under Examination
Oct 25, 2016
Approved for Publication
Aug 30, 2016
Published for Opposition
Aug 30, 2016
Registered

Basic Information

Serial Number
86974576
Filing Date
April 13, 2016
Published for Opposition
August 30, 2016
Abandonment Date
November 25, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 25, 2019
Classes
005

Rights Holder

JANSSEN SCIENCES IRELAND UNLIMITED COMPANY

79
Address
BARNAHELY
RINGASKIDDY, CO. CORK
IE

Ownership History

Janssen Sciences Ireland UC

Original Applicant
99
Little Island Co. Cork IE

Janssen Sciences Ireland UC

Owner at Publication
99
Little Island Co. Cork IE

JANSSEN SCIENCES IRELAND UNLIMITED COMPANY

New Owner After Publication #1
79
RINGASKIDDY, CO. CORK IE

Legal Representation

Attorney
Cheryl L. Foytlin

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description
Nov 25, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Nov 25, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 13, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 12, 2019 EX5G S SOU EXTENSION 5 GRANTED
Apr 10, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 10, 2019 EXT5 S SOU EXTENSION 5 FILED
Feb 6, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 4, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 2, 2018 EXT4 S SOU EXTENSION 4 FILED
Oct 2, 2018 EX4G S SOU EXTENSION 4 GRANTED
Mar 27, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 23, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 23, 2018 EXT3 S SOU EXTENSION 3 FILED
Mar 23, 2018 EX3G S SOU EXTENSION 3 GRANTED
Oct 28, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 27, 2017 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 27, 2017 EX2G S SOU EXTENSION 2 GRANTED
Oct 20, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 20, 2017 EXT2 S SOU EXTENSION 2 FILED
Mar 10, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 8, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 8, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 8, 2017 EXT1 S SOU EXTENSION 1 FILED
Mar 8, 2017 EX1G S SOU EXTENSION 1 GRANTED
Oct 25, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 30, 2016 PUBO A PUBLISHED FOR OPPOSITION
Aug 30, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 10, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 28, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 27, 2016 DOCK D ASSIGNED TO EXAMINER
Apr 18, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2016 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
human pharmaceutical preparations for the treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic disorders, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005